Lakefront Biotherapeutics | GLPG - Ingresos Por Ventas





Ventas Cambio Fecha
argenx SE USD 1.36B 240M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Biogen USD 2.74B 490M 2026-06
Genmab DKK 1.16B 259M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Incyte USD 1.67B 400M 2026-06
Merck EUR 5.43B 300M 2026-06
Neurocrine Biosciences USD 959M 148M 2026-06
Novartis USD 14.41B 1.3B 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.95B 710M 2026-06
UCB EUR 4.25B 764M 2025-12
Vertex Pharmaceuticals USD 3.33B 340M 2026-06